Veru Inc. (VERU)

Business: Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers.

IPO Date: 19-Jul-1990

Chairman, Pres & CEO: Dr. Mitchell S. Steiner F.A.C.S, F.A.C.S., M.D.

Vice Chairman & Chief Corp. Officer: Dr. Harry Fisch F.A.C.S., M.D.

Listing: NASDAQ: VERU

Country: United States

Headquarters: Miami, FL

Website: https://www.verupharma.com

Market cap: $1,009.73 Mln

Revenue (TTM): $60.47 Mln

Earnings (TTM): $-27.55 Mln

Cash: $112.02 Mln

Total Debt: $20.24 Mln

Insider's Holding: 19.48%

Liquidity: Low

52 Week range: $4.34 - 17.77

Shares outstanding: 80,073,696

10 Years Aggregate:

• CFO: $-11.00 Mln
• EBITDA: $-3.83 Mln
• Net Profit: $-17.38 Mln